Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment
Epirubicin (EPI) is an anti-cancerous chemotherapeutic drug that is an effective epimer of doxorubicin with less cardiotoxicity. Although EPI has fewer side effects than its analog, doxorubicin, this study aims to develop EPI nanoparticles as an improved formula of the conventional treatment of EPI...
Main Authors: | Salam Massadeh, Iman Almohammed, Eman Barhoush, Mustafa Omer, Nouf Aldhawi, Abdulaziz Almalik, Manal Alaamery |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/13/8/1212 |
Similar Items
-
Effect of Epirubicin Against Glioma Initiating Cells
by: Atsushi Nakajima, et al.
Published: (2020-11-01) -
The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models
by: Dezhi Sui, et al.
Published: (2022-02-01) -
A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01) -
Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
by: Tan H, et al.
Published: (2021-12-01) -
Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
by: Javier Pérez Quiñones, et al.
Published: (2022-01-01)